S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.99%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.99%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.99%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.99%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
LON:SPH

Sinclair Pharma (SPH) Share Forecast, Price & News

GBX 31.80
0.00 (0.00%)
(As of 11/5/2018)
Compare
Today's Range
31.80
31.80
50-Day Range
31.80
31.80
52-Week Range
14.45
32
Volume
373,221 shs
Average Volume
3.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SPH stock logo

About Sinclair Pharma (LON:SPH) Stock

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

SPH Price History

SPH Stock News Headlines

PRISCILLA A. SINCLAIR
Christine A. Sinclair
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Dr. William R. Sinclair
Dr. Peter Sinclair
Tiffany Sinclair
Dr. Cassandra S. Sinclair
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Sinclair Reports Second Quarter 2022 Financial Results
Sinclair Pharma Share Chat
(LSE:ACHL)
LiveLeak's reign of gory terror is over after 15 years
See More Headlines
Receive SPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Christopher P. Spooner
    CEO & Exec. Director
  • Mr. Alan Musgrave Olby (Age 47)
    CFO & Director
  • Ms. Jayne Burrell (Age 43)
    Group Gen. Counsel & Company Sec.
  • Ms. Emilie Croissant
    Head of Europe & Global Marketing
  • Mr. Nairn McMaster
    Head of Latin America













SPH Stock - Frequently Asked Questions

How have SPH shares performed in 2023?

Sinclair Pharma's stock was trading at GBX 31.80 on January 1st, 2023. Since then, SPH shares have increased by 0.0% and is now trading at GBX 31.80.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Sinclair Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sinclair Pharma investors own include Vectura Group (VEC), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), ASOS (ASC), Cracker Barrel Old Country Store (CBRL), Jack in the Box (JACK).

What is Sinclair Pharma's stock symbol?

Sinclair Pharma trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

How do I buy shares of Sinclair Pharma?

Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sinclair Pharma's stock price today?

One share of SPH stock can currently be purchased for approximately GBX 31.80.

How many employees does Sinclair Pharma have?

The company employs 2,021 workers across the globe.

How can I contact Sinclair Pharma?

Sinclair Pharma's mailing address is 1st Fl Whitfield Court, 30-32 Whitfield Street, LONDON, W1T 2RQ, United Kingdom. The official website for the company is www.sinclairispharma.com. The specialty pharmaceutical company can be reached via phone at +44-20-74676920.

This page (LON:SPH) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -